SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 41 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 75N93021C00015
National Institutes of Health
Grant: R01AI152236
National Institutes of Health
Grant: R21AI142638
National Institutes of Health
Grant: T32AI007324
National Institutes of Health
Grant: T32AI055400
National Institutes of Health
Grant: U19AI082630
NIAID NIH HHS
Grant: T32 AI070077
NIAMS NIH HHS
Grant: T32 AR076951
National Institutes of Health
Grant: 2U19AI082630-06
Reversal of Immune Failure with Viral Cure in Chronic HCV Infection
National Institutes of Health
Grant: 5R21AI142638-02
A VSV vectored vaccine for emergent tick-born phleboviruses
National Institutes of Health
Grant: 2T32AI007324-06A2
TRAINING IN VIROLOGY
National Institutes of Health
Grant: 5R01AI152236-05
Development of vaccines targeting a tick-borne phlebovirus
National Institutes of Health
Grant: 4T32AI055400-14
Training in Emerging Infectious Diseases
National Institute of Allergy and Infectious Diseases
U.S. Department of Health and Human Services
University of Pennsylvania
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals